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Severe malaria anemia is characterized by inhibited/altered erythropoiesis and frequent 
presence of hemozoin (HZ)-laden bone-marrow macrophages. HZ mediates peroxidation of 
unsaturated fatty acids and production of terminal aldehydes such as 4- hydroxynonenal 
(HNE). Present data show that HZ-laden human monocytes inhibited growth of co-incubated 
human primary erythroid cells and produced HNE that diffused to co-incubated cells 
generating HNE-protein adducts. Co-incubated HZ or low-micromolar HNE inhibited growth 
of developing human erythroid cells interfering with cell-cycle without inducing apoptosis. 
Two critical proteins in cell-cycle regulation, p53 and p21, were increased and the 
retinoblastoma protein, central regulator of G1- to S-phase transition, was consequently 
hypophosphorylated. The resultant decrease of cyclin A and D2 expression retarded cell-cycle 
progression in both erythroid cells and the K562 cell line. As a second major effect, HZ and 
HNE inhibited the protein expression of transferrin  receptor 1, Stem Cell Factor receptor (c-
kit), interleukin-3 receptor  and erythropoietin receptor, all crucial for erythroid growth. The 
reduced receptor expression and the impaired cell-cycle activity decreased cells expressing 
glycophorin A and hemoglobin. Present data confirm the inhibitory role of HZ, identify HNE 
as one inhibitory molecule and describe multiple molecular targets of HNE in erythroid 
precursors possibly involved in erythropoiesis inhibition in malaria anemia. 
 
